| scholarly article | Q13442814 |
| P2093 | author name string | Rong-Fu Wang | |
| Helen Y Wang | |||
| Yukiko Kiniwa | |||
| Guangyong Peng | |||
| Weiyi Peng | |||
| Kook Heon Seo | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell function | Q95674809 |
| toll-like receptor | Q408004 | ||
| dendritic cell | Q506253 | ||
| P304 | page(s) | 334-348 | |
| P577 | publication date | 2007-07-26 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway | |
| P478 | volume | 27 |
| Q33685646 | A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma |
| Q36674426 | A new effect of IL-4 on human γδ T cells: promoting regulatory Vδ1 T cells via IL-10 production and inhibiting function of Vδ2 T cells |
| Q97420850 | Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity |
| Q54983373 | Ability of γδ T cells to modulate the Foxp3 T cell response is dependent on adenosine. |
| Q35684372 | Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development |
| Q38848219 | Adoptive Cellular Therapy (ACT) for Cancer Treatment |
| Q39704837 | Analysis of tumor-infiltrating gamma delta T cells in rectal cancer |
| Q28390573 | Anti-tumor immunity: Myeloid leukocytes control the immune landscape |
| Q28392329 | Antigen specificity of gammadelta T cells depends primarily on the flanking sequences of CDR3delta |
| Q41088480 | Assay of Peripheral Regulatory Vδ1 T Cells in Ankylosing Spondylitis and its Significance. |
| Q38151057 | At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias |
| Q54962852 | Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. |
| Q94452062 | Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells |
| Q45033408 | CD39: A new surface marker of mouse regulatory γδ T cells |
| Q36232078 | CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome |
| Q35937473 | CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis |
| Q34946005 | CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells |
| Q38283536 | Cancer Immunotherapy Using γδT Cells: Dealing with Diversity |
| Q97653023 | Cancer immunotherapy with γδ T cells: many paths ahead of us |
| Q38288055 | Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking |
| Q92840410 | Changes of peripheral blood Vδ1 T cells in patients with atherosclerotic cerebral infarction |
| Q38685999 | Characterization of γδ T cells in patients with non-small cell lung cancer |
| Q34677859 | Clinical applications of gamma delta T cells with multivalent immunity |
| Q92839233 | Clinical significance of Vδ1 T cell detection in sepsis patients |
| Q36444174 | Complex Role of γδ T-Cell-Derived Cytokines and Growth Factors in Cancer |
| Q64996165 | Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis. |
| Q34681370 | Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy |
| Q39460093 | Critical Role of γ4 Chain in the Expression of Functional Vγ4Vδ1 T Cell Receptor of Gastric Tumour‐Infiltrating γδT Lymphocytes |
| Q35215158 | Current advances in T-cell-based cancer immunotherapy |
| Q37729208 | Current progress in γδ T-cell biology. |
| Q60241555 | Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor |
| Q33562231 | Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation |
| Q38217512 | Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field? |
| Q59798150 | Deciphering the Contribution of γδ T Cells to Outcomes in Transplantation |
| Q85562496 | Decitabine facilitates the generation and immunosuppressive function of regulatory γδT cells derived from human peripheral blood mononuclear cells |
| Q53191662 | Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer |
| Q37547414 | Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection |
| Q35285757 | Direct Toll-Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies |
| Q26863724 | Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation |
| Q64064028 | Distribution and functions of γδ T cells infiltrated in the ovarian cancer microenvironment |
| Q26773124 | Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus |
| Q38632866 | Diverse gene expression patterns in response to anticancer drugs between human and mouse cell lines revealed by a comparative transcriptomic analysis |
| Q35587132 | Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma. |
| Q91694680 | EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study |
| Q41061926 | Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives". |
| Q37139813 | Enhancing Cancer Immunotherapy by Intracellular Delivery of Cell-Penetrating Peptides and Stimulation of Pattern-Recognition Receptor Signaling |
| Q35506504 | Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer |
| Q35111018 | Flanking V and J Sequences of Complementary Determining Region 3 of T Cell Receptor (TCR) δ1 (CDR3δ1) Determine the Structure and Function of TCRγ4δ1 |
| Q96954527 | Flow Cytometric Pattern of TCRVδ Subtype Expression Rapidly Identifies γδT Cell Lymphoma |
| Q46132169 | Functional Conversion and Dominance of γδ T Subset in Mouse Experimental Autoimmune Uveitis |
| Q55431748 | Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia. |
| Q47742552 | Gamma-delta (γδ) T cells: friend or foe in cancer development? |
| Q37764294 | Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity |
| Q26863418 | Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer |
| Q90220072 | Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity |
| Q35800373 | Host Transcriptional Profiles and Immunopathologic Response following Mycobacterium avium subsp. paratuberculosis Infection in Mice |
| Q90433736 | Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature |
| Q82235091 | Human Vδ1-T cells regulate immune responses by targeting autologous immature dendritic cells |
| Q39396311 | Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. |
| Q61445430 | Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15 |
| Q38283534 | Human gamma delta T regulatory cells in cancer: fact or fiction? |
| Q39436573 | Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes |
| Q52908064 | Human peripheral gammadelta T cells possess regulatory potential |
| Q36220716 | Human regulatory T cells induce T-lymphocyte senescence |
| Q51887184 | Human tumor‐infiltrating Th17 cells have the capacity to differentiate into IFN‐γ+ and FOXP3+ T cells with potent suppressive function |
| Q37714642 | Human γδT-cell subsets and their involvement in tumor immunity. |
| Q36099417 | Hyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosus |
| Q47217155 | IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population. |
| Q37038620 | IL-23 receptor expression on γδ T cells correlates with their enhancing or suppressive effects on autoreactive T cells in experimental autoimmune uveitis |
| Q45372624 | IL-32: A Host Proinflammatory Factor against Influenza Viral Replication Is Upregulated by Aberrant Epigenetic Modifications during Influenza A Virus Infection |
| Q39016421 | IL-7 receptor blockade inhibits IL-17-producing γδ cells and suppresses melanoma development |
| Q39057617 | Immune targets and neoantigens for cancer immunotherapy and precision medicine |
| Q36106053 | Immunity, inflammation, and cancer: an eternal fight between good and evil |
| Q47557991 | Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ Recombinations. |
| Q43057295 | In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients |
| Q50581496 | Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma |
| Q89097166 | Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes |
| Q27021507 | Influence of maternal immunization with allergens on the thymic maturation of lymphocytes with regulatory potential in children: a broad field for further exploration |
| Q27008342 | Innate and adaptive immune cells in the tumor microenvironment |
| Q39041026 | Innate immune signaling and regulation in cancer immunotherapy |
| Q55065364 | Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells. |
| Q38240851 | Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses |
| Q37777344 | Insights into the role of Toll-like receptors in modulation of T cell responses |
| Q43262544 | Interleukin-17-producing gammadelta+ T cells protect NOD mice from type 1 diabetes through a mechanism involving transforming growth factor-beta |
| Q85637567 | Intragraft Vδ1 γδ T Cells With a Unique T-Cell Receptor Are Closely Associated With Pediatric Semiallogeneic Liver Transplant Tolerance |
| Q36334797 | JAK/STAT3 signaling pathway mediates endothelial-like differentiation of immature dendritic cells |
| Q33855566 | Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications |
| Q34229437 | Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection |
| Q88697944 | Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression |
| Q34944118 | Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. |
| Q50916680 | Mitochondrial damage-associated molecular patterns activate γδ T-cells |
| Q37805517 | Modulation of toll-like receptor function has therapeutic potential in autoimmune disease |
| Q37874203 | Modulation of γδ T cell responses by TLR ligands |
| Q24309046 | NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways |
| Q34612943 | Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis |
| Q92072347 | Novel Insight Into the Molecular and Metabolic Mechanisms Orchestrating IL-17 Production in γδ T Cells |
| Q50042996 | Percentage and function of CD4+CD25+ regulatory T cells in patients with hyperthyroidism |
| Q33433724 | Percentage of Peripheral CD19+CD24hiCD38hi Regulatory B Cells in Neonatal Sepsis Patients and Its Functional Implication |
| Q35016866 | Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. |
| Q38172562 | Phenotypic and functional plasticity of gamma-delta (γδ) T cells in inflammation and tolerance |
| Q50708147 | Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma |
| Q34652408 | Plasticity of γδ T Cells: Impact on the Anti-Tumor Response |
| Q57300020 | Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression |
| Q52653110 | Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation. |
| Q44728053 | Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood |
| Q91650557 | Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies |
| Q38890450 | Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy. |
| Q97521548 | Regulatory T Cells in Pregnancy: It Is Not All About FoxP3 |
| Q37599669 | Regulatory T cells and immune tolerance to tumors |
| Q38161354 | Regulatory T cells in colorectal cancer: from biology to prognostic relevance |
| Q48231687 | Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition |
| Q38787725 | Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer |
| Q88008277 | Regulatory functions of γδ T cells |
| Q27007830 | Role of natural killer and Gamma-delta T cells in West Nile virus infection |
| Q38093573 | Roles of γδ T cells in the pathogenesis of autoimmune diseases |
| Q89969652 | Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy |
| Q59335796 | Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology |
| Q35376137 | Size does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity |
| Q37238831 | Specific recruitment of γδ regulatory T cells in human breast cancer. |
| Q37224027 | Subpopulations of bovine WC1(+) gammadelta T cells rather than CD4(+)CD25(high) Foxp3(+) T cells act as immune regulatory cells ex vivo |
| Q54206007 | Suppression of tumor growth induced by human 4-1BBL-B7-H3 gene in reconstructed immune function in severe combined immunodeficient mice |
| Q41118007 | TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance |
| Q35097411 | TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B. |
| Q37741025 | TGFbeta and cancer metastasis: an inflammation link. |
| Q36850457 | TLR agonists: our best frenemy in cancer immunotherapy |
| Q37051003 | TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours |
| Q52649195 | TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy |
| Q40157170 | TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy |
| Q34880391 | TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence |
| Q57815155 | TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy |
| Q47570715 | TLRs/NLRs: Shaping the landscape of host immunity. |
| Q53160550 | TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications |
| Q38016451 | The Multifunctionality of Human Vγ9Vδ2 γδ T Cells: Clonal Plasticity or Distinct Subsets? |
| Q26765027 | The Role of γδ T Cells in Systemic Lupus Erythematosus |
| Q42155981 | The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. |
| Q34215380 | The co-stimulatory effects of MyD88-dependent Toll-like receptor signaling on activation of murine γδ T cells |
| Q92628379 | The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome |
| Q39221795 | The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner |
| Q34132804 | The future potential for cocaine vaccines |
| Q37118142 | The impact of T-cell immunity on ovarian cancer outcomes |
| Q34982772 | The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells. |
| Q36274970 | The role of chemotherapy and operation on lymphocytes accumulation in peripheral blood obtained from patients with oral squamous cell carcinoma |
| Q57107786 | The role of gamma delta T lymphocytes in breast cancer: a review |
| Q38020491 | The role of innate immune signals in antitumor immunity |
| Q59806979 | Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells |
| Q92404800 | Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond |
| Q89509415 | Toll-like Receptors from the Perspective of Cancer Treatment |
| Q33658124 | Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings |
| Q37186819 | Toll-like receptor signalling on Tregs: to suppress or not to suppress? |
| Q37051007 | Toll-like receptors and immune regulation: implications for cancer therapy |
| Q93162748 | Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies |
| Q47141380 | Tregs: Where We Are and What Comes Next? |
| Q93074359 | Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma |
| Q36800215 | Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer |
| Q38287973 | Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment. |
| Q37706085 | Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects. |
| Q38572896 | Tumor-associated galectin-3 modulates the function of tumor-reactive T cells |
| Q36625669 | Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence |
| Q53399267 | Tumor-infiltrating CD39+γδTregs are novel immunosuppressive T cells in human colorectal cancer |
| Q39714121 | Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis |
| Q89295006 | Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer |
| Q33384062 | Up-regulation of cell surface Toll-like receptors on circulating gammadelta T-cells following burn injury |
| Q37945304 | Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance |
| Q35781453 | Vasohibin-1 suppresses colon cancer |
| Q37168337 | Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity |
| Q26849323 | What lessons can be learned from γδ T cell-based cancer immunotherapy trials? |
| Q40363063 | gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection |
| Q26995102 | γδ T Cell Immunotherapy-A Review |
| Q41057828 | γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation |
| Q55340793 | γδ T Cells in Peripheral Blood of Glioma Patients. |
| Q54326921 | γδ T Cells: Unexpected Regulators of Cancer Development and Progression |
| Q27007775 | γδ T cell and other immune cells crosstalk in cellular immunity |
| Q92826000 | γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer |
| Q38718920 | γδT Cells and Related Diseases |
| Q92929734 | γδT Cells in Lung Cancer Malignant Pleural Effusion: Friend? Foe? |
Search more.